Reijiro Arakawa

779 citations
11 papers · 684 indexed · h-index 9
Topics
Cholesterol and Lipid Metabolism (9 papers)Drug Transport and Resistance Mechanisms (7 papers)Peroxisome Proliferator-Activated Receptors (7 papers)
Partner nations
JapanUnited States

In The Last Decade

Reijiro Arakawa

11 papers receiving 677 citations

Peers

Reijiro Arakawa
Comparison fields: 5 of 52
  • Surgery 576
  • Molecular Biology 417
  • Oncology 356
  • Biochemistry 99
  • Cancer Research 98
Replace Yuika Ikeda with:
Yuika Ikeda Japan
Michi Hayashi Japan
Catherine L. Knapper United States
Seth M. Klein United States
Chris Daige United States
Mehrdad Haghpassand United States
Hansook Kim Chong United States
Amir Babiker Sweden
Tadashi Koieyama Japan
Diane Thomas United States
Reijiro Arakawa relative to Yuika Ikeda Japan Yuika Ikeda's profile →
Citations per field
00.5×1.7×
Yuika Ikeda · 1×
Citations per year

Countries citing papers authored by Reijiro Arakawa

Since Specialization
Citations

This map shows the geographic impact of Reijiro Arakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reijiro Arakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reijiro Arakawa more than expected).

Fields of papers citing papers by Reijiro Arakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reijiro Arakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reijiro Arakawa. The network helps show where Reijiro Arakawa may publish in the future.

Co-authorship network of co-authors of Reijiro Arakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Reijiro Arakawa. A scholar is included among the top collaborators of Reijiro Arakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reijiro Arakawa. Reijiro Arakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 3
2 4
3 40
4 43
5 74
6 64
7 66
8 43
9 180
10 82
11 85

About Reijiro Arakawa

Reijiro Arakawa is a scholar working on Oncology, Ophthalmology and Surgery, having authored 11 papers that have together received 684 indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). The work is most often cited by research in Biochemistry (99 citations), Oncology (356 citations) and Surgery (576 citations). Reijiro Arakawa has collaborated with scholars based in Japan and United States. Frequent co-authors include Shinji Yokoyama, Sumiko Abe-Dohmae, Rui Lu, Noriyuki Iwamoto, Kazumitsu Ueda, Norimasa Tamehiro, Tomoko Nishimaki‐Mogami, Jin‐ichi Ito, Bryan Brewer and Alan T. Remaley. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026